Loss of Trex1 in Dendritic Cells Is Sufficient To Trigger Systemic Autoimmunity.
Katrin PeschkeMartin AchleitnerKathrin FrenzelAlexander GerbauletServi Remzi AdaNicolas ZellerStefan LienenklausMatthias LescheClaire PouletRonald NaumannAndreas DahlUrsula RavensClaudia GüntherWerner MullerKlaus-Peter KnobelochMarco PrinzAxel RoersRayk BehrendtPublished in: Journal of immunology (Baltimore, Md. : 1950) (2016)
Defects of the intracellular enzyme 3' repair exonuclease 1 (Trex1) cause the rare autoimmune condition Aicardi-Goutières syndrome and are associated with systemic lupus erythematosus. Trex1(-/-) mice develop type I IFN-driven autoimmunity, resulting from activation of the cytoplasmic DNA sensor cyclic GMP-AMP synthase by a nucleic acid substrate of Trex1 that remains unknown. To identify cell types responsible for initiation of autoimmunity, we generated conditional Trex1 knockout mice. Loss of Trex1 in dendritic cells was sufficient to cause IFN release and autoimmunity, whereas Trex1-deficient keratinocytes and microglia produced IFN but did not induce inflammation. In contrast, B cells, cardiomyocytes, neurons, and astrocytes did not show any detectable response to the inactivation of Trex1. Thus, individual cell types differentially respond to the loss of Trex1, and Trex1 expression in dendritic cells is essential to prevent breakdown of self-tolerance ensuing from aberrant detection of endogenous DNA.
Keyphrases
- dendritic cells
- immune response
- nucleic acid
- systemic lupus erythematosus
- regulatory t cells
- single cell
- multiple sclerosis
- cell therapy
- circulating tumor
- poor prognosis
- metabolic syndrome
- stem cells
- inflammatory response
- escherichia coli
- cell free
- magnetic resonance imaging
- adipose tissue
- insulin resistance
- case report
- biofilm formation
- quantum dots
- amino acid
- label free
- candida albicans
- sensitive detection